Whether or not you have a current employee or dependent with this condition on your plan, it’s important for employers understand the financial exposure of hemophilia. A single member with hemophilia can result in a sudden and unexpected high-cost claimant burden of $300K to $1M. This brief offers practical, evidenced based strategies to optimize outcomes and control health care spend. Taking a proactive approach through thoughtful plan design and ensuring vendor accountability is a prudent way to minimize the costs related to this rare, but very high-cost disease.